SAGE Therapeutics Inc (NASDAQ:SAGE)

38.56
Delayed Data
As of Sep 23
 -0.72 / -1.84%
Today’s Change
27.36
Today|||52-Week Range
47.75
-9.36%
Year-to-Date
No recent news for SAGE Therapeutics Inc.

Today’s Trading

Previous close39.22
Today’s open38.87
Day’s range37.51 - 38.89
Volume427,934
Average volume (3 months)666,900
Market cap$2.3B
Data as of 4:00pm ET, 09/23/2022

Growth & Valuation

Earnings growth (last year)-166.94%
Earnings growth (this year)-11.40%
Earnings growth (next 5 years)+17.25%
Revenue growth (last year)-99.43%
P/E ratioNM
Price/Sales395.66
Price/Book1.30

Competitors

----
----
XENEXenon Pharmaceutical...-1.56-4.21%
----
Data as of 4:00pm ET, 09/23/2022

Financials

Next reporting dateNovember 2, 2022
EPS forecast (this quarter)-$2.22
Annual revenue (last year)$6.3M
Annual profit (last year)-$457.9M
Net profit margin-7,258.91%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts